Trial Parameters
Condition NAFLD
Sponsor Ziekenhuis Oost-Limburg
Study Type INTERVENTIONAL
Phase N/A
Enrollment 138
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-07-01
Completion 2026-07-01
All Conditions
Interventions
FibroScan
Brief Summary
To determine the prevalence of NAFLD in T1DM patients.
Eligibility Criteria
Inclusion Criteria: * T1DM * ≥ 18 years of age * Written informed consent obtained Exclusion Criteria: * Excessive alcohol use * Exclusion of other causes of liver disease and secondary causes of liver steatosis